Lisa Su 10b5-1 Plan: Option Exercise at $34.19 and $160+ Share Sales
Rhea-AI Filing Summary
Insider activity by AMD CEO Lisa T. Su: The report shows the exercise of 224,727 stock options at an exercise price of $34.19, resulting in an acquisition of those shares. The Reporting Person sold a total of 225,000 shares in multiple transactions at weighted-average prices ranging from about $162.27 to $165.59, with reported weighted-average sale prices of $163.06, $163.76, $164.65, and $165.45 across the respective sale tranches. After these transactions, the Reporting Person beneficially owns 3,359,748 shares directly, plus additional shares held indirectly through several Grantor Retained Annuity Trusts and GRATs.
Positive
- Exercise of 224,727 options at $34.19 indicates long-term compensation realization and continued stake accumulation.
- Large retained direct ownership: Reporting Person continues to hold 3,359,748 shares directly plus material indirect trust holdings.
Negative
- Sales of 225,000 shares executed at prices around $162–$165 represent significant insider dispositions under the 10b5-1 plan.
- Substantial share turnover in a short period may be viewed by some investors as monetization that reduces insider-held float.
Insights
TL;DR: CEO exercised long-dated options and sold a tranche of shares under a 10b5-1 plan; holdings remain substantial.
The exercise of 224,727 options at $34.19 indicates realization of long-term compensation rather than an opportunistic market sale, particularly since the exercise and the subsequent sales were executed pursuant to a Rule 10b5-1 plan. The CEO still holds over 3.35 million shares directly, with additional indirect holdings via multiple GRAT/GRAT-like trusts, preserving alignment with shareholders. The disclosed sales total 225,000 shares executed across price bands near $162–$165, which is a meaningful but not controlling percentage of reported holdings.
TL;DR: Option exercise at low exercise price plus high-price sales increased liquidity while maintaining concentrated ownership.
The option exercise at $34.19 created 224,727 common shares acquired, while contemporaneous sales of 225,000 shares at weighted-average prices in the low-$160s likely generated significant proceeds. Net direct holdings remain large at 3,359,748 shares, supported by additional indirect trust holdings (several six-figure positions). For investors, the transactions reflect routine executive monetization under a pre-established plan, not an unplanned disposal signaling distress.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option Grant | 224,727 | $0.00 | -- |
| Exercise | Common Stock | 224,727 | $34.19 | $7.68M |
| Sale | Common Stock | 19,620 | $163.06 | $3.20M |
| Sale | Common Stock | 138,093 | $163.76 | $22.61M |
| Sale | Common Stock | 65,787 | $164.65 | $10.83M |
| Sale | Common Stock | 1,500 | $165.45 | $248K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. Transaction executed in multiple trades at prices ranging from $162.27 to $163.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Transaction executed in multiple trades at prices ranging from $163.27 to $164.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Transaction executed in multiple trades at prices ranging from $164.27 to $165.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Transaction executed in multiple trades at prices ranging from $165.29 to $165.59 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The options vest 1/3 on each of August 9, 2020, 2021 and 2022.
